Company Quick10K Filing
Reshape Lifesciences
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 29 $7
10-Q 2019-11-14 Quarter: 2019-09-30
10-Q 2019-08-19 Quarter: 2019-06-30
10-Q 2019-05-20 Quarter: 2019-03-31
10-K 2019-05-16 Annual: 2018-12-31
10-Q 2018-11-14 Quarter: 2018-09-30
10-Q 2018-08-20 Quarter: 2018-06-30
10-Q 2018-05-15 Quarter: 2018-03-31
10-K 2018-04-02 Annual: 2017-12-31
10-Q 2017-11-14 Quarter: 2017-09-30
10-Q 2017-08-08 Quarter: 2017-06-30
10-Q 2017-05-15 Quarter: 2017-03-31
10-K 2017-03-08 Annual: 2016-12-31
10-Q 2016-11-14 Quarter: 2016-09-30
10-Q 2016-08-12 Quarter: 2016-06-30
10-Q 2016-05-10 Quarter: 2016-03-31
10-K 2016-03-28 Annual: 2015-12-31
10-Q 2015-11-09 Quarter: 2015-09-30
10-Q 2015-08-07 Quarter: 2015-06-30
10-Q 2015-05-08 Quarter: 2015-03-31
10-K 2015-03-13 Annual: 2014-12-31
10-Q 2014-11-12 Quarter: 2014-09-30
10-Q 2014-08-08 Quarter: 2014-06-30
10-Q 2014-05-13 Quarter: 2014-03-31
10-K 2014-03-27 Annual: 2013-12-31
10-Q 2013-11-08 Quarter: 2013-09-30
10-Q 2013-08-08 Quarter: 2013-06-30
10-Q 2013-05-10 Quarter: 2013-03-31
10-K 2013-03-07 Annual: 2012-12-31
10-Q 2012-11-08 Quarter: 2012-09-30
10-Q 2012-08-08 Quarter: 2012-06-30
10-Q 2012-05-10 Quarter: 2012-03-31
10-Q 2011-11-04 Quarter: 2011-09-30
10-Q 2011-08-05 Quarter: 2011-06-30
10-Q 2011-05-06 Quarter: 2011-03-31
10-K 2011-03-07 Annual: 2010-12-31
10-Q 2010-11-08 Quarter: 2010-09-30
10-Q 2010-08-06 Quarter: 2010-06-30
10-Q 2010-05-07 Quarter: 2010-03-31
10-K 2010-03-29 Annual: 2009-12-31
8-K 2020-03-26 Earnings, Exhibits
8-K 2020-02-28 Officers, Exhibits
8-K 2019-11-14 Earnings, Exhibits
8-K 2019-10-31 Shareholder Vote
8-K 2019-10-30 Officers, Other Events, Exhibits
8-K 2019-10-18 Leave Agreement, Accountant
8-K 2019-09-04 Accountant, Exhibits
8-K 2019-08-01 Officers
8-K 2019-06-13 Enter Agreement, Exhibits
8-K 2019-05-20 Earnings, Exhibits
8-K 2019-05-08 Officers
8-K 2019-04-12 Officers, Other Events, Exhibits
8-K 2019-03-28 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-03-26 Earnings, Officers, Exhibits
8-K 2019-02-01 Sale of Shares, Shareholder Rights, Amend Bylaw, Exhibits
8-K 2019-01-28 Officers
8-K 2018-12-27
8-K 2018-12-17 Enter Agreement, M&A, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2018-11-28 Other Events
8-K 2018-11-26 Enter Agreement, Other Events, Exhibits
8-K 2018-11-14 Earnings, Exhibits
8-K 2018-11-07 Amend Bylaw, Exhibits
8-K 2018-10-30 Shareholder Vote
8-K 2018-10-29
8-K 2018-10-02 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-09-20 Sale of Shares
8-K 2018-09-17 Enter Agreement, Other Events, Exhibits
8-K 2018-09-13 Shareholder Vote, Other Events, Exhibits
8-K 2018-09-05 Officers
8-K 2018-08-22
8-K 2018-08-14 Earnings, Exhibits
8-K 2018-08-08 Leave Agreement, Officers, Other Events
8-K 2018-07-27 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2018-07-10 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2018-06-19 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2018-06-08 Officers
8-K 2018-06-07 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2018-06-01 Amend Bylaw, Exhibits
8-K 2018-05-23 Enter Agreement, Officers, Shareholder Vote, Exhibits
8-K 2018-05-15
8-K 2018-05-14 Earnings, Exhibits
8-K 2018-04-24 Officers
8-K 2018-04-02 Earnings, Exhibits
8-K 2018-03-28 Enter Agreement, Exit Costs, Shareholder Rights, Amend Bylaw, Exhibits
8-K 2018-03-20 Other Events
8-K 2018-02-01 Earnings, Exhibits
8-K 2018-01-31 Regulation FD, Other Events, Exhibits

Reshape Lifesciences Financials

RSLS Metrics, Comps, Filings

Annual | Quarterly

Business

The Company is a developer of minimally invasive medical devices that advance bariatric surgery to treat obesity and metabolic diseases. The Company’s current portfolio includes the LAP-BAND® Adjustable Gastric Banding System and the ReShape VestTM, an investigational device, to help treat more patients with obesity. Our vision is to be recognized as a leading medical technology company focused on the design, development and commercialization of transformative technology to treat obesity and metabolic diseases.

The Lap-Band System, which we acquired from Apollo Endosurgery, Inc. (“Apollo”), in December 2018, is designed to provide minimally invasive long-term treatment of severe obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The Lap-Band System is an adjustable saline-filled silicone band that is laparoscopically placed around the upper part of the stomach through a small incision, creating a small pouch at the top of the stomach, which slows the passage of food and creates a sensation of fullness. The procedure can normally be performed as an outpatient procedure, where the patient is able to go home the day of the procedure without the need for an overnight hospital stay.

The Lap-Band System has been in use in Europe since 1993 and received the CE mark in 1997. FDA approval for the Lap-Band System in the U.S. was obtained in 2001 and the Lap-Band System has been approved in many countries around the world. More than 860,000 Lap-Band Systems have been distributed worldwide.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Giga Tronics (GIGA) 8,058 42% 735.4 -4% 8,753 6,345 11,951 5,069 -379 10 7,354
Janel (JANL) 9,201 30% 8.8 1% 55,266 39,850 63,607 18,943 689 1,329 11,652
Citadel Exploration (COIL) 7,833 0% -3.8 -40% 5,933 7,408 279 0 -2,363 -1,983 7,627
Torotel (TTLO) 8,394 39% 4.4 18% 12,289 6,879 25,942 10,206 2,253 2,439 10,746
Quest Patent Research (QPRC) 7,661 31% -46.2 -31% 3,785 9,509 2,028 628 -1,183 -204 9,416
Lithium (LTUM) 7,652 32.1 28% 808 12 0 0 226 226 7,255
Voltari (VLTC) 7,646 0% -82.9 -9% 22,429 27,876 1,584 0 -1,934 -363 30,082
Mentor Capital (MNTR) 3,702 29% -1.0 -59% 5,269 1,972 3,177 930 -3,131 -3,080 2,951
Valuesetters (VSTR) 8,306 99% 6.9 54% 2,193 1,554 1,689 1,671 1,177 1,200 8,275
Capstone Companies (CAPC) 7,501 22% 109.3 0% 6,855 961 11,741 2,576 11 48 5,195
Reshape Lifesciences (RSLS) 92 65% 0.2 -111% 44,183 59,845 11,039 7,190 -49,150 -49,297 -7,625
ForeverGreen (FVRG) 7,387 77% 43.6 -50% 3,316 11,504 11,815 9,132 -1,674 178 7,750
Castle AM (CTAM) 7,373 0% 45.0 -8% 346,985 382,366 433,570 0 -28,503 5,827 261,951
Sonic Foundry (SOFO) 7,343 73% -4.2 -24% 15,180 21,433 34,781 25,501 -3,612 -2,241 9,445
Ethema Health (GRST) 7,193 0% -1.2 -32% 23,469 33,429 599 0 -7,507 -6,127 7,192
Fision (FSSN) 7,467 85% -1.7 -314% 1,589 5,112 376 320 -4,992 -4,983 8,249
nFusz (FUSZ) 73,574 0% -8.8 -1,777% 597 2,880 32 0 -10,610 -8,150 71,597
International Stem Cell (ISCO) 7,018 62% -5.0 -19% 8,260 4,636 6,635 4,138 -1,551 -1,322 6,555
Flexpoint Sensor Systems (FLXT) 9,971 96% -39.5 -10% 5,171 3,667 691 662 -501 -247 9,766
Star Gold (SRGZ) 6,966 -29.3 -31% 751 35 0 0 -235 -235 6,865

Balance Sheet ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash28,48822,30923,29711,6007,9273,31110,1635,548
Accounts Receivable5218358144489917
Inventory1,0691,2711,1289811,6861,7902,817985
PP&E6306102,82148232620143964
Assets32,48626,09626,38814,38611,5877,04188,70546,273
Accounts Payable4343411273991721,3121,0881,627
Long-Term Debt2,8816,6842,8683,40001,300
Liabilities12,44514,22211,7087,7217,9144,10212,33814,610
Stockholders' Equity20,04111,87514,6796,6643,6732,93976,36731,662
Income Statement ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue3112927871,011607
Cost of Revenue232125431172164
Gross Profit80167355351442
R&D16,67310,66811,07511,0328,1415,1695,7755,722
SG&A8,58311,96113,65914,56219,89217,98225,98419,262
Tax-2,315-3,447
Net Income-25,997-23,460-25,781-26,129-25,499-23,361-33,818-81,152
Cash Flow ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating-19,935-22,479-18,426-19,384-22,606-20,656-24,588-20,077
Cash Investing5,067924-216-89-39-14-6,368-10,328
Cash Financing12,51615,37719,6307,79418,95316,05337,80833,203